CoChat

Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic Rats via Suppression of Aldose Reductase, Oxidative Stress, and MAPK Signaling Pathway

Liu, Fei, Ma, Ying, Xu, Yanli · 2020 · Endocrine, Metabolic & Immune Disorders - Drug Targets

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Background Due to the increased prevalence of diabetes-associated complications of the eye like diabetic retinopathy and cataract, the need for a novel therapeutic agent is urgent. Due to the advantages that the polyphenolic compounds enjoy in diabetes and associated complications, we postulated that Taxifolin (TXF), a poly-phenolic flavanol, could show anti-retinopathic and anti-cataract effect in diabetes-induced rats. Methods TXF at a dose of 10, 25, and 50 mg/kg was given by oral route to STZ mediated diabetic rats for a time period of 10 weeks. The opacity of lens was studied after every 7 days of treatment till 10 weeks; evaluation of the severity of cataract and changes in the histology of lens as well as retina was done. Tissue homogenates of lens isolated after the end of the study were evaluated for markers of oxidative stress, levels of aldose reductase, p38MAPK, VEGF, and ERK1/2. Results Outcomes suggested that TXF improved retinopathy and cataract in diabetes-induced rats. The treatment of TXF also improved the status of oxidative stress and inhibited the levels of p38MAPK, VEGF, and ERK1/2. The treatment also improved the lens opacity in diabetic rats. The results suggest that the protective effect of TXF against cataract and retinopathy may be due to the anti-oxidative potential of TXF and its inhibiting effect on VEGF, ERK1/2, p38MAPK, and aldose reductase. Conclusion The study confirms that TXF is a potential candidate showing a protective effect against diab…

Overview

Integrity signals

Registry

Crossref · 10.2174/1871530319666191018122821

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Research works printed but not linked: 2

  1. Xie X.; Feng J.; Kang Z.; Zhang S.; Zhang L.; Zhang Y.; Li X.; Tang Y.; Taxifolin protects RPE cells against oxidative stress-induced apoptosis. Mol Vis 2017,23,520-528
  2. Stefek M.; Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip Toxicol 2011,4(2),69-77 · DOI

Cited by

See all 31

Metadata

Authors
Liu, F., Ma, Y., & Xu, Y.
Affiliations
Dalian Medical University (CN)
Corresponding author
Xu, Yanli
Venue
Endocrine, Metabolic & Immune Disorders - Drug Targets
Published
2020-05-18
Volume
20
Issue
4
Pages
599-608
ISSN
1871-5303 (ISSN-L)
OpenAlex
W2982561660
Cited by
26
References
54
Citations by year
2025: 5 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 1
FWCI
1.46
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Metabolic & Immune Disorders - Drug Targets (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
taxifolin, diabetic cataract, diabetic retinopathy, streptozotocin-induced diabetes, aldose reductase, oxidative stress, MAPK signaling, p38 MAPK, ERK1/2, vascular endothelial growth factor, lens opacity, flavan-3-ols, polyphenols, diabetic eye complications
MeSH terms
Aldehyde Reductase, Animals, Cataract, Diabetes Mellitus, Experimental, Diabetic Retinopathy, Dose-Response Relationship, Drug, Male, Quercetin, Streptozocin, Rats, Wistar, Oxidative Stress, MAP Kinase Signaling System, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic Rats via Suppression of Aldose Reductase, Oxidative Stress, and MAPK Signaling Pathway. https://app.cochat.ai/papers/10.2174/1871530319666191018122821
The paper
Liu, F., Ma, Y., & Xu, Y. (2020). Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic Rats via Suppression of Aldose Reductase, Oxidative Stress, and MAPK Signaling Pathway. Endocrine, Metabolic & Immune Disorders - Drug Targets. https://doi.org/10.2174/1871530319666191018122821

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.